CCTG IC.8 COV-IMMUNO- A randomized phase III trial of immunization with IMM-101 versus observation for the prevention of serious respiratory and COVID-19 related infections in cancer patients at increased risk of exposure

/1 Comment/in /by
Lead Investigator(s): Rebecca Auer (The Ottawa Hospital), Chris O’Callaghan (Queen’s University) Co-Investigators: John Bartlett, Laszlo Radvanyi, Dongsheng Tu, Janet Dancey, Scott Halperin, Kelvin Chan, Nicole Mittmann, Martin Smoragiewicz, Grainne O’Kane, George Zogopoulos, Jonathon Loree, Rosalyn Juergens, Eric Winquist, Judy Needham, David Roberge ARCC Program Area(s): Health Technology Assessment Main Funder/Other (more…)
The Canadian Centre for Applied Research in Cancer Control

Assessing the Real-World Clinical and Economic Outcomes of Emerging Innovative Technologies in Oncology: The Cases of Biosimilars and CAR T-cells

/0 Comments/in /by
Lead Investigator(s): Kelvin Chan, Scott Gavura, Wanrudee Isaranuwatchai Lead Institution: Sunnybrook Research Institute Co-Investigators: Jaclyn Beca, Wei Fang Dai, Jessica Arias, Lisa Milgram, Elaine Meertens, Arthur Manzon, Sherrie Hertz, Sean Hopkins, Tom Kouroukis, Chris Bredeson, William Wai Lun Wong, Petros Pechlivanoglou, Pierre Villeneuve, Sumit Gupta, Alexandra Chambers, Christine Chen, Lee (more…)
The Canadian Centre for Applied Research in Cancer Control

CanREValue: Developing a Framework for the Incorporation of Real World Evidence into Cancer Drug Funding Decisions in Canada

/0 Comments/in /by
  Lead Investigator(s): Kelvin Chan, Stuart Peacock, Wanrudee Isaranuwatchai, Mina Tadrous, Michael Sherar Lead Institution: Sunnybrook Research Institute Co-Investigators: Riaz Alvi, Jaclyn Beca, Yvonne Bombard, Melissa Brouwers, Winson Cheung, Janet Dancey, Claire de Oliveira, Craig Earle, Jeffrey Hoch, Robin McLeod, Nicole Mittmann, Petros Pechlivanoglou, Eleanor Pullenayegum, Maureen Trudeau, ARCC Program (more…)